Skip to content

Clinical trials

Phase 2 Temporomandibular Joint Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Temporomandibular Joint Disorders Phase: Phase 2 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20071
20121
20152
20161
20171
20181
20191
20201
20213
20221
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status3
Recruiting2
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Complementary and Integrative Health (NCCIH)2
National Institute of Dental and Craniofacial Research (NIDCR)2
Capnia, Inc.1
Duke University1
Federal University of Paraíba1
Federal University of Rio Grande do Sul1
Hospital of the Ministry of Interior, Kielce, Poland1
Indiana University1
Johns Hopkins University1
Karolinska Institutet1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Temporomandibular Joint Disorders24
Pain3
Agnosia2
Chronic Pain2
Temporomandibular Joint Dysfunction Syndrome2
Back Pain1
Craniomandibular Disorders1
Cystitis, Interstitial1
Endometriosis1
Facial Pain1

Trials

Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.